©The Author(s) 2026.
World J Gastroenterol. Jan 14, 2026; 32(2): 112132
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.112132
Published online Jan 14, 2026. doi: 10.3748/wjg.v32.i2.112132
Figure 2 Findings in relation to rs174538 mutation.
A: For serum and erythrocyte membranes, and rd.d6di. bP < 0.05 for wild vs hetero; B: For serum and erythrocyte membranes, and d5di. cP < 0.05 for wild vs homo, dP < 0.0001 for wild vs homo, eP < 0.001 for wild vs hetero, fP < 0.05 for hetero vs homo; C: For serum and erythrocyte membranes, and arachidonic acid. gP < 0.001 for wild vs homo, hP < 0.001 for wild vs hetero, iP < 0.05 for wild vs homo, jP < 0.01 for wild vs hetero. 1ANOVA, followed by Tukey’s HSD test. Rrd.d6di: Red blood cell redefined δ6 desaturase index; Srd.d6di: Serum redefined δ6 desaturase index; rd5di: Red blood cell δ5 desaturase index; sd5di: Serum δ5 desaturase index; rAA: Red blood cell arachidonic acid; sAA: Serum arachidonic acid.
- Citation: Matsuzawa H, Ito Z, Uchiyama K, Motoi Y, Ohtaki Y, Iwashita Y, Suzuki S, Nakada T, Koido S, Kojima K, Murohashi K, Saruta M, Ohkusa T, Kubota T. Association of FADS2 polymorphism rs174538 with fatty acid metabolism and disease severity in Japanese patients with Crohn’s disease. World J Gastroenterol 2026; 32(2): 112132
- URL: https://www.wjgnet.com/1007-9327/full/v32/i2/112132.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i2.112132